Blueberries Medical Corp. (BBM.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 11.04 Thousand CAD | -92.06% |
| 2022 | 138.98 Thousand CAD | -37.77% |
| 2021 | 223.33 Thousand CAD | -82.6% |
| 2020 | 1.28 Million CAD | 107.47% |
| 2019 | 618.66 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 11.13 Thousand CAD | 0.0% |
| 2024 Q2 | 10.15 Thousand CAD | 0.0% |
| 2023 Q3 | 150.55 Thousand CAD | -2.18% |
| 2023 FY | 11.04 Thousand CAD | -92.06% |
| 2023 Q2 | 153.9 Thousand CAD | 6.75% |
| 2023 Q4 | 11.04 Thousand CAD | -92.67% |
| 2023 Q1 | 144.16 Thousand CAD | 3.73% |
| 2022 Q4 | 138.98 Thousand CAD | -27.04% |
| 2022 Q3 | 190.48 Thousand CAD | -2.27% |
| 2022 FY | 138.98 Thousand CAD | -37.77% |
| 2022 Q2 | 194.91 Thousand CAD | -10.4% |
| 2022 Q1 | 217.54 Thousand CAD | -2.59% |
| 2021 Q3 | 291.49 Thousand CAD | -77.41% |
| 2021 Q2 | 1.29 Million CAD | 1.44% |
| 2021 Q4 | 223.33 Thousand CAD | -23.39% |
| 2021 Q1 | 1.27 Million CAD | -0.9% |
| 2021 FY | 223.33 Thousand CAD | -82.6% |
| 2020 Q2 | 502.73 Thousand CAD | -2.77% |
| 2020 FY | 1.28 Million CAD | 107.47% |
| 2020 Q4 | 1.28 Million CAD | -1.09% |
| 2020 Q3 | 1.29 Million CAD | 158.12% |
| 2020 Q1 | 517.05 Thousand CAD | -16.42% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q2 | 3800.00 CAD | 0.0% |
| 2019 Q3 | 3701.00 CAD | -2.61% |
| 2019 Q4 | 618.66 Thousand CAD | 16616.08% |
| 2019 FY | 618.66 Thousand CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | - CAD | -Infinity% |
| Ayurcann Holdings Corp. | 129.01 Thousand CAD | 91.442% |
| The BC Bud Corporation | - CAD | -Infinity% |
| BioNxt Solutions Inc. | - CAD | -Infinity% |
| CordovaCann Corp. | 3.31 Million CAD | 99.667% |
| Christina Lake Cannabis Corp. | 4.48 Million CAD | 99.754% |
| Captor Capital Corp. | 5.47 Million CAD | 99.798% |
| City View Green Holdings Inc. | - CAD | -Infinity% |
| 1CM Inc. | 4.14 Million CAD | 99.734% |
| Global Hemp Group Inc. | 3.55 Million CAD | 99.69% |
| Greenway Greenhouse Cannabis Corporation | 7.37 Million CAD | 99.85% |
| IM Cannabis Corp. | 394 Thousand CAD | 97.197% |
| Lobe Sciences Ltd. | - CAD | -Infinity% |
| Maple Leaf Green World Inc. | - CAD | -Infinity% |
| Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
| Nextleaf Solutions Ltd. | 384.69 Thousand CAD | 97.13% |
| Ovation Science Inc. | 18.26 Thousand CAD | 39.552% |
| Pharmadrug Inc. | - CAD | -Infinity% |
| Captiva Verde Wellness Corp. | - CAD | -Infinity% |
| RAMM Pharma Corp. | 179.76 Thousand CAD | 93.857% |
| RIV Capital Inc. | 144.15 Million CAD | 99.992% |
| Revive Therapeutics Ltd. | - CAD | -Infinity% |
| Red White & Bloom Brands Inc. | 21.42 Million CAD | 99.948% |
| SLANG Worldwide Inc. | 3.16 Million CAD | 99.651% |
| 1933 Industries Inc. | 12.57 Million CAD | 99.912% |
| Red Light Holland Corp. | 291.08 Thousand CAD | 96.207% |
| Top Strike Resources Corp. | 1.7 Million CAD | 99.351% |
| Xebra Brands Ltd. | - CAD | -Infinity% |
| Adastra Holdings Ltd. | 147.51 Thousand CAD | 92.515% |